The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
CONCLUSIONS Increased expression of SPINK13 was associated with poor prognosis in patients with CCRCC.
PMID: 31825950 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Epithelial Cancer | Genetics | Kidney Cancer | Renal Cell Carcinoma | Research | Science | Study